US SEC Filings Daily Market Digest — September 03, 2026

03-09-2026

DRC Medicine Inc. filed this 8-K to disclose that on September 2, 2026, Ribbon Acquisition Corp., DRC Medicine Ltd., and investor Meteora Select Trading Opportunities Master, LP entered into a series of financing agreements (Forward Purchase Agreement, Subscription Agreement, Standby Equity Purchase Agreement, and Convertible Promissory Note) to support the closing of the previously announced business combination (SPAC merger). The agreements provide up to $100 million in equity commitment (SEPA) and an initial $1,212,121 pre-paid convertible note (with a 17.5% original issue discount), alongside a forward purchase of up to 4,100,000 shares. While these financings strengthen the go-forward balance sheet, they include significant dilution potential (up to 9.9% of post-combination shares escrowed, 19.99% exchange cap, and conversion discounts up to 5% below market) and a 7% payment premium on the note, representing material costs and risks for existing shareholders.

• · The Forward Purchase Agreement allows the Investor to receive a prepayment equal to Initial Price × number of shares, funded from the Company's trust account, and settles in cash six months after closing (subject to extension).
• · Per-share reference price under Forward Purchase Agreement: $10.00 for first 30 days, then resets weekly to the lower of $10.00 and prior week's VWAP.
• · Subscription Agreement: Investor may subscribe up to the Maximum Number of Shares (less Recycled Shares) at Initial Price, capped at 9.9% beneficial ownership unless waived.
• · Note: $1M cash for $1.212M principal (17.5% OID); matures 12 months after closing; 0% interest unless default (then 18% per annum); 7% payment premium on amounts paid/ redeemed.
• · Note conversion: lower of fixed price and 95% of lowest VWAP over prior 5 trading days, subject to floor and 9.9% ownership limit.
• · SEPA: No minimum usage requirement; no fee on unused commitment; issuance subject to effective registration statement, trading volume limits, and Nasdaq 19.99% exchange cap.
• · Escrow: 9.9% of post-closing Common Shares deposited by certain PubCo shareholders; on Note default, title transfers to Investor as partial liquidated damages.
• · Registration Rights Agreement: Company must file resale registration statement within 30 days of closing and use best efforts to have it effective within 60 days (90 if SEC reviews).

03-09-2026

Equity Bancshares, Inc. (EQBK) announced a definitive merger agreement to acquire Lincoln Bancorp, parent of Lincoln Savings Bank, for approximately $123.8 million in a mix of stock (77.5%) and cash (22.5%). The deal adds 16 Iowa locations and is expected to close in Q4 2026, subject to regulatory and shareholder approvals. The transaction is projected to be accretive to EPS by 5.1% in 2027 and 7.5% in 2028, though tangible book value per share dilution is expected to be earned back in less than three years.

• · Equity's stock price used for valuation: $49.85 as of September 2, 2026.
• · Transaction expected to be $0.27 accretive to 2027 EPS and $0.42 accretive to 2028 EPS.
• · Estimated tangible book value per share dilution earned back in less than three years.
• · Equity has completed 27 total strategic transactions since 2002, including 15 whole-bank acquisitions since its IPO in 2015.
• · Lincoln Savings Bank operates 16 locations in Iowa cities including Adel, Allison, Ankeny, Aplington, Cedar Falls, Clive, Des Moines, Garwin, Greene, Grinnell, Hudson, Lincoln, Nashua, Reinbeck, Tama, and Waterloo.

03-09-2026

Crown PropTech Acquisitions (CPTKW) has entered into an amended and restated business combination agreement with Mkango Rare Earths Limited and its subsidiaries, dated September 2, 2026. The transaction involves a merger where Mkango (Cayman) Limited will merge into Crown PropTech, with Mkango BVI becoming the public company (PubCo). The deal includes a pre-closing reorganization, share adjustments, and various covenants related to mining licenses, debt-to-equity exchanges, and offtake arrangements. No financial figures or period-over-period comparisons are provided in this filing.

• · The agreement amends and restates a prior business combination agreement (Original Agreement).
• · Mkango BVI will become PubCo after closing.
• · The transaction includes a Shareholder Support Agreement and Sponsor Support Agreement.
• · Conditions include a Minimum Cash Condition and regulatory approvals.
• · The agreement includes provisions for a PubCo Incentive Plan and D&O indemnification.
• · OTC Markets quotation is referenced for SPAC securities.
• · The filing does not disclose the equity value or any financial terms of the transaction.

03-09-2026

Concrete Pumping Holdings (BBCP) reported strong Q3 FY2026 results with revenue up 13% YoY to $116.8M and Adjusted EBITDA up 13% to $30.4M, driven by robust demand for large-scale commercial and infrastructure projects, particularly data centers. However, the U.K. segment saw net income decline to $0.5M from $0.7M and Adjusted EBITDA fall to $3.2M from $3.9M, while gross margin slipped slightly to 38.7% from 39.0% due to fuel cost inflation. The company raised its full-year outlook, initiated a quarterly cash dividend of $0.13 per share, and extended its share repurchase program.

• · G&A expenses increased to $30.1M from $27.5M, driven by higher stock-based compensation ($0.8M) and professional fees ($0.4M), but as a percentage of revenue declined to 25.8% from 26.5%.
• · U.S. Concrete Pumping net income improved to $2.0M from $1.6M, while U.S. Concrete Waste Management Services net income increased to $2.4M from $1.4M.
• · U.K. Operations net income declined to $0.5M from $0.7M, and Adjusted EBITDA fell to $3.2M from $3.9M, impacted by fuel cost inflation and higher repair and maintenance activity.
• · The company raised its full-year FY2026 revenue guidance to $425M-$435M (from $410M-$425M), Adjusted EBITDA guidance to $103M-$108M (from $98M-$105M), and free cash flow guidance to approximately $50M (from $45M).
• · The share repurchase program was extended from December 31, 2026 to November 30, 2028, with approximately $11.9M remaining available.
• · The initial quarterly dividend of $0.13 per share is payable on October 2, 2026 to holders of record on September 18, 2026.
• · Residential and light commercial construction remain challenged, and U.K. market conditions are subdued.
• · The company expects to incur approximately $17.1M in additional accelerated 2027 capital expenditures in Q4 FY2026 due to stricter U.S. emissions laws taking effect January 1, 2027.

03-09-2026

Teva Pharmaceutical disclosed a cumulative goodwill impairment of $29.6 billion as of December 31, 2025 and 2024, up from $28.3 billion in 2023, indicating a stable impairment level year-over-year. The company received $500 million in milestone payments in Q4 2025 for duvakitug (anti-TL1A) Phase 3 initiation, and also received a $500 million upfront payment in Q4 2023 for the same asset. Teva completed significant debt management in 2025, including repaying $1.812 billion in senior notes at maturity and extinguishing $2.289 billion in notes via a cash tender offer, while issuing $2.2 billion in new senior notes. However, the company reported a $10 million loss on the extinguishment and faces potential interest rate increases of 0.100%-0.375% per annum if sustainability targets are not met.

• · Teva entered into $500 million notional cross-currency swaps in May 2025 to hedge USD debt into CHF.
• · Teva purchased $40 million of Alvotech subordinated convertible bonds in September 2023, which were redeemed in July 2024.
• · State taxes in Ulm made up the majority (greater than 50%) of the tax effect in the 'other' category in 2025.
• · Teva's long-term employee-related obligations are presented under other taxes and long-term liabilities.
• · Teva uses foreign exchange contracts (options and forwards) to hedge balance sheet items and projected revenues/expenses in multiple currencies.

03-09-2026

U S GLOBAL INVESTORS INC (GROW) filed its 10-K annual report for the fiscal year ended June 30, 2026. Total operating revenues increased 21.3% to $10.251M, driven by strong growth in USGIF advisory fees (+128.2%) and ETF advisory fees for gold/natural resources (+72.8%) and technology/aerospace/defense (+870.0%). However, total ETF advisory fees declined 6.8% due to a 16.5% drop in airline, travel and cargo ETF fees, and total operating expenses decreased 5.1% to $10.854M, with general and administrative expenses down 7.8% and advertising down 22.0%. The company's U.S.-Based ETFs saw net redemptions of $139.304M during the year, while USGIF funds had net purchases of $52.354M.

• · Employee compensation and benefits remained nearly flat at $4.958M in FY2026 vs $4.931M in FY2025 (+0.5%).
• · Interest expense increased 500% from $1K to $6K, though the absolute amount is minimal.
• · Depreciation expense decreased 31.1% from $61K to $42K.
• · USGIF Fixed Income funds had zero advisory fees in both years.
• · Average investment management fee for USGIF Equity increased from 0.76% to 0.88%, while U.S.-Based ETFs fee decreased slightly from 0.60% to 0.59%.
• · Net shareholder redemptions for U.S.-Based ETFs were $139.304M in FY2026, compared to $531.658M in FY2025, showing a significant slowdown in outflows.
• · USGIF Equity had net shareholder purchases of $54.369M in FY2026 vs net redemptions of $11.385M in FY2025.

03-09-2026

Market Technology Acquisition Corp, a blank-check company, reported a net loss of $53,197 for the period from inception (April 10, 2026) through June 30, 2026, with no revenue and no cash on hand. The company has not yet completed an initial public offering (IPO) and relies on related-party promissory notes and sponsor funding to cover formation and administrative costs. Total assets were $210,720, while total liabilities were $238,917, resulting in a shareholder's deficit of $28,197.

• · No revenue generated during the period.
• · Cash balance at end of period was $0.
• · Net cash used in operating activities was $0.
• · Formation, general, and administrative costs totaled $53,197.
• · Deferred offering costs of $185,038 were paid through the IPO Promissory Note.
• · Prepaid expenses of $25,000 were paid by the Sponsor in exchange for Class B Ordinary Shares.
• · The company is a shell company and an emerging growth company.
• · The company has not yet completed its IPO; the IPO Promissory Note is related party debt.
• · As of September 3, 2026, Class A Ordinary Shares outstanding increased to 21,212,500, while Class B Ordinary Shares decreased to 6,833,333.

03-09-2026

Planet Labs PBC reported Q2 FY27 revenue of $116.1M, up 58.1% YoY from $73.4M, driven by strong growth in Defense & Intelligence (up 93.3% to $81.0M) and EMEA (up 135.2% to $55.2M). Net loss narrowed significantly to $9.4M from $22.6M in the prior year quarter, and operating cash flow was positive at $68.4M for the first half. However, the company reported a net loss of $148.2M for the six-month period, compared to $35.2M in the prior year, largely due to a $106.5M non-cash charge from the change in fair value of warrant liabilities. Total stockholders' equity improved to $564.4M from $188.4M at year-end, supported by $122.4M in ATM equity proceeds and $107.8M in warrant exercises.

• · Gross profit for Q2 FY27 was $65.6M (56.5% margin) vs $42.3M (57.6% margin) in Q2 FY26.
• · Total operating expenses for Q2 FY27 were $79.1M, up 31.4% from $60.2M in Q2 FY26.
• · Research and development expense for Q2 FY27 was $35.2M, up 45.6% from $24.2M.
• · Sales and marketing expense for Q2 FY27 was $21.5M, up 22.3% from $17.6M.
• · General and administrative expense for Q2 FY27 was $22.5M, up 21.6% from $18.5M.
• · Interest income for Q2 FY27 was $6.4M, up from $2.2M in Q2 FY26.
• · Interest expense for Q2 FY27 was $1.4M, up from $0.3M in Q2 FY26.
• · Deferred revenue (current) increased to $281.2M at July 31, 2026 from $220.6M at January 31, 2026.
• · Public and private placement warrant liabilities were $0 at July 31, 2026, down from $173.3M at January 31, 2026, due to exercise/conversion.
• · Accumulated deficit widened to $(1,598.1M) at July 31, 2026 from $(1,449.9M) at January 31, 2026.
• · Capital expenditures (property and equipment) for H1 FY27 were $44.7M, up 57.2% from $28.4M in H1 FY26.
• · Cash and cash equivalents plus restricted cash totaled $423.6M at July 31, 2026, up from $235.6M at January 31, 2026.
• · The company had $450.3M in short-term investments at July 31, 2026, up from $410.6M at January 31, 2026.
• · Accounts receivable decreased to $59.9M at July 31, 2026 from $83.5M at January 31, 2026.
• · Inventories increased to $8.9M at July 31, 2026 from $6.1M at January 31, 2026.
• · Goodwill remained relatively flat at $142.7M vs $143.5M at year-end.
• · Operating lease right-of-use assets increased to $48.9M from $14.6M at year-end.
• · Operating lease liabilities (current and non-current) totaled $50.4M at July 31, 2026, up from $15.6M at January 31, 2026.
• · Stock-based compensation for H1 FY27 was $33.5M, up 28.9% from $26.0M in H1 FY26.
• · Basic and diluted net loss per share for Q2 FY27 was $(0.03), improving from $(0.07) in Q2 FY26.
• · Basic and diluted net loss per share for H1 FY27 was $(0.42), worsening from $(0.12) in H1 FY26.

03-09-2026

Domo, Inc. reported a net loss of $9.6M for Q2 FY27 (three months ended July 31, 2026), a significant improvement from the $22.9M loss in the same quarter last year. Total revenue declined 3.7% YoY to $76.8M, driven by a 3.3% drop in subscription revenue ($70.4M vs $72.7M) and an 8.1% decline in professional services. However, gross margin improved to 77.1% from 74.8%, and operating expenses were cut 7.9% YoY, leading to a narrower operating loss of $2.4M (vs $7.3M). Cash and cash equivalents fell sharply to $25.1M from $42.9M at year-start, and the company drew down $137.2M of current debt while carrying $126.5M in long-term debt.

• · Cash used in operating activities was $1.2M in H1 FY27 vs $7.3M provided in H1 FY26.
• · Accounts receivable nearly halved to $47.6M from $85.5M at year-start.
• · Deferred revenue (current) fell to $143.0M from $174.9M at Jan 31, 2026.
• · Stock-based compensation expense decreased to $23.8M in H1 FY27 from $28.7M in H1 FY26.
• · The company paid $5.8M in debt forbearance fees during H1 FY27.
• · Warrant liability remeasurement provided a $1.8M gain in H1 FY27 vs a $9.3M loss in H1 FY26.
• · Total stockholders' deficit widened slightly to $187.3M from $186.1M at year-start.
• · Net loss per share improved to ($0.21) in Q2 FY27 from ($0.56) in Q2 FY26.

03-09-2026

Mama's Creations reported strong Q2 FY2027 results with revenue growing 55% YoY to $54.6M and net income more than doubling to $2.6M. Adjusted EBITDA rose 69% to $5.5M, and the company ended the quarter with $138.6M in cash following a $108.6M public offering. However, gross margin contracted slightly to 24.0% from 24.9% a year ago, though it improved sequentially from 23.6% in Q1.

• · Gross margin improved sequentially from 23.6% in Q1 FY2027 to 24.0% in Q2 FY2027, moving toward mid-to-high-20% target.
• · Operating expenses as a percentage of revenue declined 160 bps YoY to 18.5%, demonstrating improved operating leverage.
• · Cash from operations in the first six months of FY2027 was $11.9M.
• · Total debt stood at $4.8M as of July 31, 2026.
• · Company was selected for Costco's second half multi-vendor mailer across all eight regions nationally.
• · First-ever planned launch in banner Kroger, beginning with four items in over 100 stores across the Louisville division.
• · Over a dozen new placements launched in Q2, more than 60% using chicken bottoms, majority were cross-sells.
• · Over two dozen new placements approved for Q3 delivery.
• · Company invited to attend leading investor conferences including BMO, Craig-Hallum, TD Cowen, William Blair, Oppenheimer, and D.A. Davidson.

03-09-2026

Nukkleus Inc. filed an S-1 registration statement for the resale of up to 5,100,000 shares of common stock by selling stockholders, which would represent approximately 64% of outstanding shares post-issuance and cause substantial dilution. The company has undergone an unprecedented transformation from fintech to aerospace and defense but has no operational track record in the defense industry, no government contracts, and no security clearances. Financially, Nukkleus reported negative working capital of ~$131M, a stockholders' deficit of $19M, net operating losses of $7.2M for the six months ended June 30, 2026, and net cash used in operations of $9.8M, though management believes its plans (including an ELOC facility and cash-positive subsidiaries) alleviate going-concern doubts.

• · The Series B Preferred Stock has a liquidation preference of $50,000 per share, meaning in liquidation holders receive that amount before common stockholders get anything.
• · The Common Warrants have an exercise price of $266.25 per share, above recent trading prices, making cash exercise unlikely; cashless exercise via Black-Scholes formula would yield no cash proceeds to the company.
• · The second tranche of the February 2026 Private Placement ($10M) is contingent on conditions including stock price >$1.00 and 10-day average trading value ≥$900,000; if not met, the company will rely on its ELOC facility.
• · CEO Menachem Shalom also serves as CEO of Star 26, Motomova Inc., and Hold Me Ltd., creating potential conflicts of interest and divided attention.
• · The company has no defense industry track record, no government contracts, no security clearances, and no established prime contractor relationships.
• · The company is attempting to integrate multiple defense acquisitions (Star 26, Tiltan, Nimbus, ITS) across different countries and regulatory regimes without any acquisition integration experience.
• · The S-1 registers shares for resale by selling stockholders only; the company may not receive any proceeds from this offering.
• · The company's majority-owned subsidiaries Rimon Ltd. and Nimbus Drones are cash-positive and require no capital support from the parent.

03-09-2026

A group of investors led by Bastion Trading Ltd and Wei Zhu filed a Schedule 13D disclosing a 9.99% beneficial stake in SkyAI, Inc. (formerly Sharps Technology Inc.). The group acquired shares through open-market purchases and a $400 million PIPE that closed on August 25, 2025. The filing expresses deep concern over the company's underperformance, corporate governance practices, conflicts of interest, and a rushed 2026 annual meeting, and the group intends to vote 'WITHHOLD ALL' on the re-election of all five incumbent directors.

• · The group acquired 1,150,000 shares in the PIPE at $6.50 per share.
• · Bastion Trading also holds Pre-Funded Warrants for up to 4,234,615 shares at $0.0001 per share and Stapled Warrants for up to 5,384,615 shares at $9.75 per share.
• · The group is concerned about conflicts of interest related to consulting agreements with Sol Edge Limited and Sol Markets, which are controlled by director Alice Zhang's brother.
• · An independent director resigned in December 2025 due to these conflicts.
• · The company amended its bylaws to eliminate stockholder written consent and expand advance notice requirements, and adopted a poison pill without a stockholder ratification vote.
• · The 2026 annual meeting was called on only 32 days' notice.
• · The group intends to vote 'WITHHOLD ALL' on the re-election of all five incumbent directors.

03-09-2026

Steel Partners Holdings L.P. and its affiliates filed a Schedule 13D disclosing beneficial ownership of 1,907,172 shares (8.9%) of KLX Energy Services Holdings, Inc. as of August 27, 2026. The filing also reveals that SP Strategic Holdings LLC, a wholly owned subsidiary of Steel Connect, holds 1,852,239 subscription rights from a Rights Offering, entitling it to purchase up to 7,195,948 additional shares at $1.49 per share. The Reporting Persons state they believe the shares and rights were undervalued and may increase or decrease their position depending on market conditions.

• · The Rights Offering entitles holders to purchase 3.885 shares per Right at $1.49/share, with an over-subscription privilege for unsubscribed shares until September 23, 2026 (Expiration Date).
• · The Issuer may amend, extend, or cancel the Rights Offering at any time before the Expiration Date.
• · All Reporting Persons are organized under Delaware law; each individual listed is a U.S. citizen.
• · No Reporting Person or listed individual has been convicted in a criminal proceeding or subject to securities-related civil judgments in the last five years.
• · The Reporting Persons disclaim beneficial ownership of shares owned directly by another Reporting Person.

03-09-2026

BRP Inc. filed its unaudited condensed consolidated interim financial statements and MD&A for the three- and six-months ended July 31, 2026, via a Form 6-K with the SEC. The filing includes certifications from the CEO and CFO under Regulation 52-109F2. No specific financial figures or performance trends are disclosed in the cover filing itself.

• · Filing includes Exhibits 99.1 (Financial Statements) and 99.2 (MD&A) for the three- and six-months ended July 31, 2026.
• · Certifications under Regulation 52-109F2 were provided by the CEO and CFO.
• · The registrant files annual reports under Form 40-F.

03-09-2026

Diversified Energy Company announced the acquisition of Birch Permian Holdings, Inc. and affiliated companies on September 2, 2026. The deal was disclosed via a press release and an investor presentation posted on the company's website. No financial terms or performance metrics were provided in the filing.

• · The acquisition target is Birch Permian Holdings, Inc. and certain affiliated companies.
• · An investor presentation was posted on the company's website at www.div.energy under the 'Presentations' tab.
• · The press release is furnished as Exhibit 99.1 and incorporated by reference into Item 7.01.

03-09-2026

Korea Electric Power Corp (KEP) issued a 6-K filing on September 3, 2026, to clarify a media report about a proposed merger of its five power generation subsidiaries into a single entity, as part of the Korean Government's 'Plan for Functional Reform of Public Institutions.' The company states that specific details are not yet determined and will be re-disclosed within one month. No financial figures or performance metrics are provided in this filing.

• · The merger proposal involves five power generation subsidiaries of KEP.
• · The announcement was made by the Korean Government on September 3, 2026.
• · KEP will re-disclose specific details within one month from the filing date.

03-09-2026

Baozun Inc. filed a Form 6-K with the SEC to disclose its submission of a monthly return to the Hong Kong Stock Exchange regarding movements in its authorized share capital and issued shares during August 2026. The filing is a routine administrative disclosure with no financial results or material business developments. The report includes a standard safe harbor statement regarding forward-looking statements.

• · The monthly return was dated September 3, 2026 and covers share movements for August 2026.
• · The filing is made under Commission File Number 001-37385.
• · Baozun files annual reports on Form 20-F.

03-09-2026

ORIX CORP disclosed the status of its share repurchase program authorized on May 11, 2026, under which up to 100 million shares (approx. 9.1% of outstanding) for up to ¥250 billion may be bought back through March 31, 2027. As of August 31, 2026, the company had repurchased 18,052,000 shares for ¥114.1 billion, including 5,667,000 shares for ¥35.6 billion in August alone. The buyback is proceeding at a steady pace, with 18% of the authorized shares and 46% of the authorized amount utilized in the first three months.

• · Repurchase period runs from May 22, 2026 to March 31, 2027.
• · Method: market purchases via discretionary dealing contract.
• · August 2026 repurchase: 5,667,000 shares for ¥35.6 billion.

03-09-2026

HUTCHMED (China) Limited announced a licensing agreement with GSK for a KRAS-EGFR-antibody conjugate cancer therapy. The agreement was disclosed via a Form 6-K filing with the SEC on September 3, 2026. No financial terms or other quantitative details were provided in the filing.

• · The filing is a Form 6-K for the month of September 2026.
• · The registrant's address is 48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong.
• · The registrant files annual reports under Form 20-F.

03-09-2026

AITX issued a press release summarizing CEO Steven Reinharz's remarks from a September 2, 2026 investor 'Ask Me Anything' session. Topics included the ROAMEO platform, demand and manufacturing constraints, dilution, previously announced cost reductions, and operational objectives. The filing is a Regulation FD disclosure and does not contain financial results or period-over-period comparisons.

• · Press release is a summary of oral remarks, not a transcript.
• · Cost reductions were previously announced on August 3, 2026.
• · Session replay and website contents are not incorporated by reference into the filing.

03-09-2026

ICICI Bank Ltd completed the acquisition of an additional 2% stake in its subsidiary ICICI Prudential Life Insurance Company Ltd for approximately ₹14.70 billion (about $177 million) through open market purchases between July 22 and September 2, 2026. This increases ICICI Bank's shareholding in ICICI Life from around 50.8% to approximately 52.8%. The transaction was executed via stock exchange mechanisms in multiple tranches.

• · The acquisition was executed through the stock exchange mechanism in multiple tranches between July 22, 2026 and September 2, 2026.
• · The shares have a face value of ₹10 each.
• · The stake percentage is based on ICICI Life's equity share capital as of June 30, 2026.
• · This filing follows prior disclosures on February 28, 2026 and June 24, 2026 regarding the planned acquisition.

03-09-2026

TechPrecision Corporation filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held virtually on September 29, 2026. The agenda includes the election of five directors, ratification of CBIZ CPAs P.C. as independent auditor for FY2027, an advisory vote on named executive officer compensation, and approval of an amended and restated 2016 Equity Incentive Plan. As of the record date (August 27, 2026), there were 10,133,261 shares of common stock outstanding and entitled to vote.

• · Annual Meeting will be held virtually on September 29, 2026 at 10:00 a.m. Eastern Time.
• · Record date for voting is August 27, 2026.
• · Directors are elected by a majority of votes cast (uncontested election); a director receiving more 'AGAINST' than 'FOR' votes must tender resignation to the Board.
• · Proposals 1 (election of directors), 3 (advisory vote on executive compensation), and 4 (equity plan amendment) are non-routine; brokers lack discretionary authority on these.
• · Proposal 2 (ratification of auditor) is routine; brokers may vote uninstructed shares.
• · The proxy statement and annual report are available at http://www.techprecision.com/reports_and_proxy.html.

03-09-2026

Ming Shing Group Holdings Ltd closed the acquisition of Meals Through Seasons Limited for an aggregate consideration of $510,000,000, payable entirely in securities (150 million Class A ordinary shares valued at $150 million and $360 million in unsecured convertible promissory notes). The notes are divided into three annual performance tranches of $120 million each, convertible only if the company achieves at least 50% of forecast net profit after tax for the corresponding year. No cash was paid, and the notes carry no interest, no fixed maturity, and no mandatory redemption, but conversion is capped at 24% of total voting rights on a fully diluted basis.

• · The notes have no fixed maturity date and no mandatory redemption; they remain outstanding unless converted, redeemed, repurchased, or cancelled.
• · Conversion price is $1.00 per share, subject to anti-dilution adjustments for stock dividends, splits, and reclassifications.
• · If a performance tranche fails to meet the 50% NPAT threshold, it remains outstanding but never becomes convertible, even if later years meet the threshold.
• · The company has no obligation to repay principal on any fixed date and may not redeem or repurchase notes without holder consent.
• · The notes rank pari passu with all other unsecured unsubordinated obligations of the company.

03-09-2026

Hafnia Limited filed a Form 6-K with the SEC on September 3, 2026, disclosing the accelerated vesting of share options and restricted share units under its long-term incentive plan. The announcement was made via a press release attached as Exhibit 99.1. No financial figures were provided in the filing, and the event appears to be a routine corporate governance update with no immediate financial impact disclosed.

• · The filing is incorporated by reference into Hafnia's Form F-3 registration statement (File No. 333-287637), effective May 29, 2025.
• · The press release is dated September 3, 2026, and the filing was signed by CFO Petrus Wouter Van Echtelt.

03-09-2026

Alterity Therapeutics Ltd, a development-stage enterprise, filed a Form 6-K with the SEC on September 3, 2026, announcing it will present at the Cantor Global Healthcare Conference. The filing is a routine foreign issuer report and does not contain any financial results or material operational updates.

03-09-2026

Inventiva S.A. filed a Form 6-K with the SEC on September 2, 2026, attaching a press release issued the same day. The filing provides no financial or operational details beyond the existence of the press release.

• · Filing is a Form 6-K (foreign private issuer report) for the month of September 2026.
• · The press release is dated September 2, 2026, and is attached as Exhibit 99.1.
• · The registrant's principal executive offices are located at 50 rue de Dijon, 21121 Daix, France.

03-09-2026

Toyota Motor Corporation announced a share repurchase program authorizing the buyback of up to 500 million shares for a maximum total purchase price of JPY 1,000 billion (approx. USD 6.8B) over a one-year period starting August 5, 2026. As of August 31, 2026, the company had repurchased 28,211,700 shares at a cost of JPY 86,494,175,900 (approx. USD 588M), representing about 5.6% of the authorized amount by value. The buyback is being executed through open market purchases.

• · The repurchase program runs from August 5, 2026 to August 4, 2027.
• · The repurchases are conducted through open market purchases.
• · The initial repurchase period (Aug 5–31, 2026) consumed about 5.6% of the total authorized amount by value.

03-09-2026

Alchemy Investments Acquisition Corp 1 held an extraordinary general meeting on September 1, 2026, where shareholders approved a proposal to adjourn the meeting. The meeting will reconvene on September 4, 2026, and the company is continuing to accept requests from shareholders to reverse previously submitted redemption elections.

• · The meeting was adjourned to Friday, September 4, 2026 at 10:00 a.m. Eastern Time.
• · Shareholders can attend in person at Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154, or virtually at https://www.cstproxy.com/alchemyinvest/2026.
• · Shareholders seeking to reverse redemption elections should contact their broker or Continental Stock Transfer & Trust Company.

03-09-2026

Texas Ventures Acquisition III Corp (TVACW) entered into a Merger Agreement on September 2, 2026 to acquire Plus Automation, Inc. in a business combination valuing the target at an $800 million pre-money equity value. The transaction involves a domestication from Cayman Islands to Delaware, a name change to 'PlusAI Holdings, Inc.', and the issuance of up to 70 million earnout shares based on stock price targets. The deal is subject to shareholder approvals and other customary closing conditions.

• · The Merger Agreement was entered into on September 2, 2026, with the report filed on August 27, 2026.
• · The transaction involves a two-step merger: Merger Sub I merges into the Company, then the surviving corporation merges into Merger Sub II.
• · TVA will domesticate from a Cayman Islands exempted company to a Delaware corporation and change its name to 'PlusAI Holdings, Inc.'.
• · Each SPAC Class B Ordinary Share will convert into a SPAC Class A Ordinary Share immediately prior to domestication.
• · Company Class B Common Stock holders will receive SPAC Class B Common Stock with 20 votes per share.
• · Certain preferred stock and option conversions will result in SPAC Class C Common Stock with one-quarter vote per share.
• · Earnout Shares are issuable in three tranches (23,330,000; 23,330,000; 23,340,000) based on VWAP targets over any 20 trading days within 180 consecutive trading days during the 5-year earnout period.
• · Company Options and RSUs will be assumed and converted into Exchanged Options and Exchanged RSUs of Domesticated SPAC.
• · The Exchange Ratio is calculated as (Equity Value + aggregate exercise price of vested Company Options) divided by (total fully diluted shares) divided by $10.00.
• · The filing is a Form 8-K under Rule 425, classified as M&A communications.

03-09-2026

Passage Bio, Inc. entered into an Amended and Restated Merger Agreement with Remix Therapeutics on September 2, 2026, restructuring the transaction into a two-step merger to qualify as a tax-free reorganization. The deal includes a concurrent private placement financing of approximately $70.0 million through the sale of Remix common stock and/or pre-funded warrants at $1.3861 per share. The economic terms of the original agreement remain unchanged, with the outside date set for December 24, 2026, and the combined company's cash expected to fund operations into 2028.

• · The Amended and Restated Merger Agreement restructures the original deal into a two-step merger to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
• · The concurrent private placement financing is for approximately $70.0 million, with a per-share price of $1.3861 and a per-pre-funded-warrant price of $1.3860.
• · The combined company expects its cash to fund operations into 2028.
• · The outside date for closing the transaction is December 24, 2026.
• · The board of directors of both Passage Bio and Remix have approved and recommended the transaction to their respective stockholders.
• · A Registration Rights Agreement will be entered into, requiring the combined company to file a resale registration statement within 30 days after the Second Merger and use commercially reasonable efforts to have it effective within 90 days (or 120 days in case of a full SEC review).

03-09-2026

Elroy Air, the target of a proposed business combination with Inflection Point Acquisition Corp. VII (IPAC), announced the completion of the first autonomous, uncrewed flights under the U.S. DOT/FAA eVTOL Integration Pilot Program (eIPP). The Chaparral drone, capable of carrying 500+ lbs over 450 miles, conducted a week of successful test flights in Louisiana, carrying various cargo including medical supplies and spare parts. The company reports a commercial demand pipeline of over 1,400 aircraft representing more than $5 billion in potential revenue, with the first production aircraft planned for late 2026 and initial customer deliveries in 2027. The SPAC merger is expected to close in Q4 2026, with Elroy Air listing on Nasdaq.

• · The flights were conducted at Houma-Terrebonne Airport in Louisiana, one of the busiest rotorcraft airports in the U.S., under Air Traffic Control oversight.
• · Payloads during test flights weighed at least 150 pounds and included packages, medical supplies, toolboxes, food, and water.
• · The eIPP is a three-year program that will test various aircraft systems, with Elroy Air focusing on beyond-visual-line-of-sight operations.
• · Kratos Defense & Security Solutions is the exclusive U.S. manufacturer of Chaparral, producing the aircraft at its Sacramento, California facility.
• · The first production aircraft is planned for late 2026, with initial customer deliveries expected in 2027.
• · Elroy Air's key customers include Bristow Group (100 pre-ordered aircraft), The Barq Group ($200M JV), SLI Aerospace (up to 40 aircraft), the U.S. Defense Department, and FedEx.

03-09-2026

Ribbon Acquisition Corp. entered into a series of financing agreements with Meteora Select Trading Opportunities Master, LP in connection with its pending business combination with DRC Medicine Ltd. The agreements include a Forward Purchase Agreement for up to 4,100,000 shares, a Standby Equity Purchase Agreement (SEPA) for up to $100,000,000, and a $1,212,121 convertible promissory note (issued at a 17.5% discount). While the financing provides substantial liquidity for the merger, the terms are highly dilutive to existing shareholders, with the Investor receiving a 1.75% commitment fee ($1,750,000), a 7% payment premium on the note, and conversion prices as low as 95% of the lowest VWAP over five days.

• · The Forward Purchase Agreement allows the Investor to purchase up to 4,100,000 shares of PubCo common stock at the per-share redemption price.
• · The per-share reference price resets weekly after the first 30 days to the lower of $10.00 and the prior week's VWAP.
• · The SEPA has no minimum usage requirement and no fee on unused commitment.
• · The Note bears no interest absent an event of default, at which point it accrues at 18% per annum.
• · Upon closing, certain PubCo shareholders will deposit 9.9% of outstanding Common Shares into escrow.
• · The Investor has a right of first refusal on up to 33% of future financings for six months after the valuation date.
• · The Note requires 33% of net proceeds from most financings to be applied to repayment of outstanding principal.

03-09-2026

Bleichroeder Acquisition Corp. III filed a 425 communication containing social media posts from Ursa Major Technologies, including a CNBC interview transcript. In the interview, CEO Chris Spagnoletti announced that Ursa Major intends to go public in Q1 2027 via a SPAC merger with Inflection Point, having raised $350 million in a PIPE, with Inflection Point backing $100 million. The filing also includes standard forward-looking statements and risk factors regarding the proposed business combination.

• · Ursa Major intends to go public in Q1 2027 via a SPAC merger with Inflection Point.
• · The SPAC entity will be renamed 'Inflection Point Mach X Bleichroeder Corp.' and will redomesticate from the Cayman Islands to Delaware.
• · The filing includes a transcript of a CNBC 'The Exchange' broadcast from August 25, 2026.
• · CEO stated demand for hypersonic systems and solid rocket motors is at an all-time high.
• · The U.S. currently has only two suppliers for solid rocket motors (Northrop and Aerojet), and the government is seeking additional sources like Ursa Major.
• · There are currently no fielded hypersonic munition systems in the U.S.
• · The filing includes standard risk factors including potential failure to consummate the business combination, shareholder approval risks, and regulatory changes.

03-09-2026

Andretti Acquisition Corp. II entered into additional non-redemption agreements with new investors on September 1–2, 2026, under which Pubco would issue up to 550,000 Pubco Shares (if a business combination closes by June 9, 2027) plus up to 183,334 additional shares (if closed after that date) in exchange for investors agreeing not to redeem up to 2,200,000 public shares. These agreements supplement prior non-redemption agreements covering up to 900,000 Pubco Shares and 300,000 additional shares linked to 3,600,000 non-redeemed shares. The aim is to increase funds remaining in the trust account following the special meeting to extend the combination deadline to September 9, 2027.

• · The special meeting is scheduled for September 8, 2026 at 10:00 a.m. Eastern Time.
• · Non-redemption agreements will terminate if the Extension is not approved, the Company decides not to proceed, or the Investor exercises redemption rights for the non-redeemed shares.
• · The Company may enter into additional similar non-redemption agreements before the special meeting.

03-09-2026

Nicola Mining Inc. filed a Form 6-K with the SEC on September 3, 2026, for the month of August 2026, submitting a material change report dated August 28, 2026. The filing is a routine foreign issuer report and does not contain any financial results or operational metrics.

• · The material change report is dated August 28, 2026.
• · The report is incorporated by reference into the company's F-10 registration statement (File No. 333-293048).
• · The company files annual reports under Form 40-F.

03-09-2026

KT Corporation filed a Form 6-K with the SEC on September 3, 2026, signed by Sun Wook Kim (IRO) and Sanghyun Cho (IR Team Leader). The filing contains no financial data, operational updates, or material events beyond the routine foreign issuer report.

03-09-2026

Scienjoy Holding Corp (NASDAQ: SJ) announced it has entered a sale and purchase agreement to acquire a 29.9% stake in Leader Education Limited (HKSE: 1449.HK) for HK$102.69 million (approx. US$13.1 million) through its wholly-owned subsidiary Scienjoy Innovation Labs Inc. The transaction is a related-party deal as Scienjoy's independent director Jun Lu is also an executive director of Leader Education. The acquisition is subject to several conditions including satisfactory due diligence, regulatory consents, and continued listing of Leader Education shares on the Hong Kong Stock Exchange.

• · The transaction is a related-party transaction because Scienjoy's independent director Jun Lu is also an executive director of Leader Education.
• · Conditions to closing include: satisfactory due diligence, no material breach of warranties by Shuren, all necessary waivers/consents/notifications, continued listing of Leader Education shares on HKEX Main Board, and no trading suspension of Leader Education shares for more than ten consecutive business days.
• · Closing is expected five business days after the last condition is satisfied or waived.
• · Scienjoy has been developing intelligent solutions for education, including capabilities for unified development and management of course content, administrative systems, and teaching/research outcomes.
• · Leader Education operates Heilongjiang College of Business and Technology, a private undergraduate institution, and has invested in two vocational schools in the Yangtze River Delta and Beijing-Tianjin-Hebei regions.

03-09-2026

Cygnus Capital Advisors, LLC filed its 13F-HR for the quarter ended June 30, 2026, reporting 92 holdings with a total market value of approximately $147.2 million. The fund's largest positions include Newell Brands, Office Properties Income Trust, and TripAdvisor, while it also holds significant stakes in smaller, speculative names. The filing reflects a diversified portfolio across sectors, but no period-over-period comparison is available as this is a single-quarter snapshot.

• · Top holdings by value: Newell Brands ($7,348K), Office Properties Income Trust ($6,607K), Accenture ($5,236K), TripAdvisor ($5,014K), CBIZ ($5,236K).
• · Largest share counts: Alight Inc (5,949,788 shares), SunPower Inc (1,562,251 shares), Newell Brands (1,196,752 shares), Seritage Growth Properties (1,119,201 shares).
• · Portfolio includes speculative positions in micro-caps such as Actelis Networks, Arrive AI, and Nuburu.
• · Holds leveraged ETF: Leverage Shares 2x Long Adobe Daily ETF.
• · Includes international exposure via ADRs and foreign listings (e.g., Alibaba, JD.com, Novo Nordisk, VEON).

03-09-2026

Perella Weinberg Partners issued 1,999,015 shares of Class A common stock in exchange for 1,997,030 Class A partnership units of PWP OpCo and an equal number of Class B common shares held by certain limited partners, pursuant to the PWP OpCo LPA. The transaction was exempt from registration under Section 4(a)(2) of the Securities Act. This is a routine exchange under the partnership agreement, with no new capital raised and no impact on the company's financial position.

• · Exchange ratio: 1 Class A partnership unit for 1 share of Class A common stock (subject to customary adjustments).
• · Class B common stock converts at a rate of 1:1000 (0.001) per Class A unit exchanged.
• · The company has the option to deliver cash or Class A common stock in exchange for units and Class B shares.
• · The issuance was made without any form of general solicitation or general advertising.

03-09-2026

Manulife Financial Corporation filed a Form 6-K with the SEC on September 3, 2026, incorporating an Underwriting Agreement dated September 1, 2026, into its existing F-10 registration statement. The filing is a routine foreign private issuer report and does not reveal any specific financial results or strategic milestones.

03-09-2026

News Corp filed an 8-K on September 3, 2026, disclosing its daily repurchase program disclosures to the Australian Securities Exchange (ASX). The company is authorized to repurchase up to $1 billion in aggregate of its Class A and Class B common stock. The filing is a routine procedural update with no new financial results or material events.

• · The repurchase program is conducted under ASX rules requiring daily disclosure of transactions.
• · The filing includes forward-looking statements regarding the company's intent to repurchase shares from time to time.
• · Exhibits 99.1 and 99.2 contain the ASX disclosures for the respective dates.

03-09-2026

Inter & Co, Inc. filed a Form 6-K with the SEC on September 2, 2026, disclosing that the CVM Board of Commissioners has decided to discontinue the company's Sponsored Level II BDR Program. This regulatory decision will terminate the Brazilian Depositary Receipt program, which may affect the company's capital market strategy and investor base in Brazil.

• · The discontinuation was decided by the CVM Board of Commissioners.
• · The filing is for the month of August 2026.
• · The company's registered office is in the Cayman Islands, with principal executive offices in Belo Horizonte, Brazil.

03-09-2026

Apogee Enterprises announced the acquisition of GroGlass, a European provider of high-performance glass surface solutions, for up to €62.5 million (~$72.5 million) on a cash-free, debt-free basis. The acquisition is expected to contribute over $30 million in revenue at approximately 25% adjusted EBITDA margin in the first 12 months, with at least $4 million in annualized cost synergies identified. The transaction is expected to close in fiscal Q3 2027 and will be integrated into Apogee's Performance Surfaces Segment.

• · GroGlass is located in Riga, Latvia, and specializes in anti-reflective and other advanced coatings for display, architectural, and technical applications.
• · The acquisition will be financed using cash on hand and the Company’s existing credit facility.
• · The purchase price includes up to €10 million payable over 3 years dependent on GroGlass achieving certain financial targets.
• · The transaction is subject to customary closing conditions and expected to close during fiscal 2027 third quarter.
• · Apogee plans to integrate Groglass into its Performance Surfaces Segment.

03-09-2026

One and One Green Technologies (YDDL) announced it has procured more than 2,000 tons of raw materials for its new electronic sludge, copper sludge, and nickel sludge recovery line in Metro Manila, Philippines. Equipment installation is underway, and the company expects to begin production before year-end 2026. This is a positive operational milestone, but the filing contains no financial data or period-over-period comparisons, so no balanced performance assessment is possible.

• · The new production line is designed to process industrial hazardous waste including electronic sludge, copper sludge, and nickel sludge.
• · The project was first disclosed in May 2026 when the company announced the purchase of smelting equipment.
• · The company is procuring raw materials concurrently with equipment installation to have feedstock available upon completion.
• · The company holds a government-issued license to import and process hazardous waste in the Philippines.

03-09-2026

Companhia Siderúrgica Nacional (CSN) announced a leadership transition, with Benjamin Steinbruch moving to Chairman of the Board and Fabio Schvartsman appointed as CEO, effective September 3, 2026. The filing contains no financial data or performance metrics.

• · The leadership changes were approved by the Board of Directors on September 2, 2026.
• · The filing is a Material Fact disclosure under Brazilian corporate law and CVM Resolution No. 44/2021.

03-09-2026

Bank of Montreal (BMO) filed a Form 6-K with the SEC on September 3, 2026, incorporating by reference a press release announcing that it has received regulatory approvals for its Normal Course Issuer Bid (NCIB). The NCIB allows BMO to repurchase its own shares in the open market, subject to regulatory and exchange requirements. No financial figures or performance metrics were disclosed in this filing.

• · The filing incorporates by reference 15 registration statements (Form F-3 and Form S-8) filed with the SEC.
• · The NCIB regulatory approvals were received, but the press release (Exhibit 99.1) is not included in the filing content.
• · The filing is made under Form 40-F (annual report) and is for the month of September 2026.